Grant RDF
pages:- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- more...
- A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of Mk-5172/Mk-8742...
- A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of Mk-5172/Mk-8742...
- A Phase III Randomized Double Blind Placebo Controlled Study to Evaluate the Efficacy and Safety of Prochymal ..........
- A Phase III Randomized Double-blind Study of Induction (Daunorubicin/Cytarabine)and Consolidation (High Dose Cytarabin
- A Phase III Randomized Doubleblind Multicenter Parallel Group,Placebo-Controlled Study of Oral Enoximone V Placebo
- A Phase III Randomized Multicenter Clinical Trial of High- Dose Human Theraphy for Neuroprotection in Acute Stroke
- A Phase III Randomized Open-Label Study Comparing Gemcitabine Plus Cetuximab (Imc-C225) Versus Gemcitabine As First.....
- A Phase III Randomized Study of Adjuvant Ipilimumab Anti-Ctla4 Therapy Versus High-Dose Inteferon Alfa-2B for Resected H
- A Phase III Randomized Study of Oral Sapacitabine in Elderlypatients With Newly Diagnosed Acute Myeloid Leukemia
- A Phase III Randomized Trial for Patients With De Novo Aml Using Bortezomib (Ind# 58443, Nsc# 681239) and Sorafenib...
- A Phase III Randomized, Double-Blind Study of Maintenance the Therapy With Cc-5013 (Nsc- 713813, Ind- 70116.Non-Fed
- A Phase III randomized, double-blind, placebo-controlled study of sorafenib or placebo in combination with transarterial chemoembolization (TACE) performed with drug-eluting beads and doxorubicin for intermediate stage hepatocellular carcinoma (HCC)
- A Phase III Randomized, Multicenter Trial Comparing Siorlimus/Tacrolimus With Tacrolimus/Methotrexate As Gvhd Prophylaxi
- A Phase III randomized, placebo controlled, double blind trial of Sorafenib plus Erlotinib vs. Sorafenib plus placebo as First Line systemic treatment for Hepatocellular Carcinoma (HCC)
- A Phase III Rndmzd Dblbl Multi-Ctr Clinical Trial Comparing the Safety and Efficacy of Veronate Versus Plcb For
- A Phase III Study for the Sequence Optimization for Ms-325 (Gadofoveset) for Imag
- A Phase III Study of Chemotherapy With or Without Algenpantucel-L (Hyperacute-Pancreas) Immunotherapy in .....
- A Phase III Trial of Concurrent Radiation and Chemotherpay Rtog 0129
- A Phase III Trial to Determine the Efficacy of Bivalent Aidsvax B/B Vaccine in Adults at Risk of Sexually.....
- A Phase III, ....Study of the Clinical Efficacy and Safety of ICA-17043 With or Without Hydroxyurea Therapy in Patients
- A Phase III, 12 Week, Dbld, Placebo-Ctrl Efficacy & Safety Study of Preladenant in Subjects With Moderate to Severe...
- A Phase III, Adjuvant Trial Comparing Three Chemotherapy Regimens in Women With Node-Positive Breast Cancer:
- A Phase III, D/B, R/D, Placebo-Ctrl, M/C Clinical Trial to Study the Safety, Tolerability, Efficacy, & Immu of V212....
- A Phase III, Double-Blind, Placebo-Controlled, Randomized Trial to Determine the Efficacy and Safety of a Dose Range..
- A Phase III, Double-Blind, Randomized, Parallel- Group, Placebo- Controlled Study of Intravenous (Iv)....
- A Phase III, Double-Masked, Multicenter, Randomized, Sham- Controlled Study of the Efficacy and Safety of Ranibizumab..
- A Phase III, Mlt-Cntr, 18-Mo, Open-Label Safety,Tolerabilityand Efficacy Study of Adderall Xr in the Treatment of . . .
- A Phase III, Multi-Center, Randomized, Placebo Controlled Study to Evaluate the Clinical Efficacy and .....
- A Phase III, Multucenter, Double-Blind, Randomized, Placebo-Controlled 8-Week Retreatment Study of Sargramostim in .....
- A Phase III, Observer-Blinded,..Safety...Gsk Biologicals Dtpa Candidate Vaccine As Compared to Us-Licensed Td Vaccine...